Evidence map›Paper›PMID 38357347›Full record

ArticleFrontiers in microbiology2024

Prevalence and molecular characteristics of

Ying Kang, Keyi Yu, Zhenzhou Huang, Bo Pang, Shengtian Liu, Tao Peng, Ying Li, Duochun Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Metagenome-assembled genomes (MAGs) of the emerging pathogenMicrobiology resource announcements · 2025
    Article
  4. First case report ofFrontiers in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ying Kang *Shunyi District Center for Disease Control and Prevention, Beijing, China.
Keyi Yu *National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Zhenzhou Huang *Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Bo PangWorkstation for Microbial Infectious Disease, Shunyi District Center for Disease Control and Prevention, Beijing, China.
Shengtian LiuShunyi District Center for Disease Control and Prevention, Beijing, China.
Tao PengShunyi District Center for Disease Control and Prevention, Beijing, China.
Ying LiShunyi District Center for Disease Control and Prevention, Beijing, China.
Duochun WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Beijing Center for Disease Prevention and Control · CNChinese Center For Disease Control and Prevention · CNHangzhou Center for Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Stool samples were collected from diarrhea patients in a surveillance project from 2017 to 2019. Results: 1104 fecal samples were collected, and the Discussion: Monitoring for

Indexed as

antibiotic susceptibilitydiarrheamolecular characteristicsprevalenceShewanella

Identifiers

PMID38357347
PMCPMC10866003
OpenAlexW4391403653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.